Cubic Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.00 M
as on 18-07-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 Cr
as on 18-07-2024
- Satisfied Charges ₹ 5.50 M
as on 18-07-2024
- Revenue 0.41%
(FY 2023)
- Profit -10.37%
(FY 2023)
- Ebitda 27.52%
(FY 2023)
- Net Worth 19.73%
(FY 2023)
- Total Assets 76.66%
(FY 2023)
About Cubic Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.10 Cr. The company has closed loans amounting to ₹5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Mohan and Swati Bhalla serve as directors at the Company.
- CIN/LLPIN
U51397CH2014PTC035059
- Company No.
035059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cubic Lifesciences Private Limited offer?
Cubic Lifesciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Pharmaceutical Tablets, Anti-Itch Skin Cream, Brain & Nervous System Drugs, Psychotherapeutic Agents, Hand Sanitizers & Personal Hygiene, Beauty Soap, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Cubic Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohan  | Director | 09-May-2014 | Current |
| Swati Bhalla | Additional Director | 05-Dec-2019 | Current |
Financial Performance of Cubic Lifesciences.
Cubic Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.41% increase. The company also saw a substantial fall in profitability, with a 10.37% decrease in profit. The company's net worth Soared by an impressive increase of 19.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cubic Lifesciences?
In 2023, Cubic Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Promo Pharma Private LimitedActive 2 years 6 monthsChander Mohan and Swati Bhalla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jun 2022 | ₹1.10 Cr | Open |
Others Creation Date: 18 Jun 2014 | ₹5.50 M | Satisfied |
How Many Employees Work at Cubic Lifesciences?
Unlock and access historical data on people associated with Cubic Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cubic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cubic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
